TCTR20180904002招募中未知
A Comparative Study on the Level of Hepatic Steatosis and Fibrosis between Pre- and Post-Intravenous Chelation Therapy in Patients with Chronic Lead Poisoning.
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn university0 个研究点目标入组 90 人开始时间: 2018年9月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Blood lead level equal to or above 70 mcg/dl
- •Occupational lead exposure for more than 1 year
排除标准
- •Viral hepatitis B or C
- •Autoimmune hepatitis
- •Wilson disease
- •Hemochromatosis
- •Significant alcohol consumption
- •Triglyceride level >200 mg/dL
- •Waist circumference > 102 cm in men and > 88 cm in women
- •Symptoms of acute lead poisoning
- •Prior lead chelation therapy
研究者
相似试验
已完成
不适用
A comparative study on level of hepatic steatosis and fibrosis between pre-and post-chelation therapy in patients with chronic lead poisoningchronic lead poisoninghepatotoxicitysteatosisliver fibrosisGlutathioneInterleukinǃiver steatosishepatitisTCTR20191108001nit of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University86
尚未招募
不适用
Evaluation of relationships between hepatic steatosis and sleep apnea in subjects suspected to have abdominal obesity, and effects of CPAP treatment on hepatic steatosis.obstructive sleep apnea, hepatic steatosisJPRN-UMIN000007112Kyoto University Graduate School of Medicine, Department of respiratory medicine40
已完成
不适用
Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormalityonalcoholic fatty liver diseaseJPRN-UMIN000009614Yokohama City University Graduate School of Medicine100
进行中（未招募）
不适用
Quantification of Hepatic Steatosis With Different Ultrasound FrequencyFatty Liver, NonalcoholicFatty LiverUltrasoundNCT05855239Jong Keon Jang120
已完成
不适用
The diagnostic ability for hepatic steatosis using ultrasound attenuation imaging as reference standerd MRI-PDFF, liver tissue and controlled attenuation parameter(CAP); a prospective multicenter study.chronic liver diseaseJPRN-UMIN000048672Hyogo Medical University1,000